Literature DB >> 24635067

X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora.

J B Powell1, I Dokal, R Carr, S Taibjee, B Cave, C Moss.   

Abstract

Dyskeratosis congenita (DC) is a clinically and genetically heterogeneous multisystem bone marrow failure disorder of telomere maintenance, which may present with dermatological features. The main cause of mortality is bone marrow failure, often developing in the second decade of life, although pulmonary disease and malignancies such as squamous cell carcinomas (SCCs) may also prove fatal. We report the case of a 28-year-old man with X-linked DC and confirmed DKC1 gene mutation. In addition to the classic triad of nail dystrophy, hyperpigmentation and oral leucoplakia, the patient had actinic keratosis (AK) and photodamaged skin, hitherto under-recognized features of this condition. Awareness of the clinical presentation of DC is important, as accurate clinical and molecular diagnosis affords patients and their families genetic counselling, cancer prevention and screening measures, and planning for complications such as bone marrow failure.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2014        PMID: 24635067     DOI: 10.1111/ced.12272

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

Authors:  Daria V Babushok; Monica Bessler
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

2.  Dyskerin Downregulation Can Induce ER Stress and Promote Autophagy via AKT-mTOR Signaling Deregulation.

Authors:  Daniela Maiello; Marianna Varone; Rosario Vicidomini; Valentina Belli; Marina De Rosa; Paola Dama; Maria Furia; Mimmo Turano
Journal:  Biomedicines       Date:  2022-05-08

Review 3.  Biomarkers of Cellular Senescence and Skin Aging.

Authors:  Audrey S Wang; Oliver Dreesen
Journal:  Front Genet       Date:  2018-08-23       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.